Compare Globus Medical Inc. Class A Common Stock (GMED) vs Hewlett Packard Enterprise Co (HPE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Hewlett Packard Enterprise Co — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Hewlett Packard Enterprise Co trades at $61.49 (market cap $91.34B). The key difference: Hewlett Packard Enterprise Co is far larger — about 8.9× Globus Medical Inc. Class A Common Stock's market cap, and Hewlett Packard Enterprise Co pays a 0.83% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Hewlett Packard Enterprise Co for 34 Days on average.
| GMED | HPE | |
|---|---|---|
Market Cap | $10.25B | $91.34B |
Volume | 1,108,124 | 23,977,697 |
Sector | Health | Technology |
52-Week High | $96.82 | $73.46 |
52-Week Low | $58.33 | $20.01 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $9.76B | $105.37B |
Dividend Yield | — | 0.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
HPE stock trades at $63.17, down 10.14% today but remains near recent highs following strong AI infrastructure demand. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $1.11 exceeding expectations by 19%. Technical indicators show a bullish trend with support at $66 and resistance at $72. Recent news highlights a $1.2 billion AI server order from Vultr and upgraded guidance, driving positive sentiment.
HPE presents growth potential from AI infrastructure expansion and strong earnings momentum, though valuation appears elevated with a P/E of 35.47. Key risks include execution challenges in integrating Juniper Networks and competitive pressures in the server market. Analyst consensus targets $70.00 with 47.5% buy ratings, suggesting moderate upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →
